questionsmedicales.fr
Eucaryotes
Champignons
Deuteromycota
Chrysosporium
Chrysosporium : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Infections fongiques
Mycologie
Culture des champignons
PCR
Biopsie
Infections fongiques
Symptômes
Infections fongiques
Tests sérologiques
Infections fongiques
Symptômes
5
Symptômes
Infections fongiques
Infections cutanées
Chrysosporium
Infections pulmonaires
Symptômes
Infections systémiques
Chrysosporium
Prévention
5
Prévention
Infections fongiques
Immunodépression
Prévention
Prévention
Infections fongiques
Traitements
5
Antifongiques
Chrysosporium
Traitement
Infections fongiques
Durée du traitement
Antifongiques
Effets secondaires
Antifongiques
Hospitalisation
Infections fongiques
Complications
5
Complications
Infections fongiques
Mortalité
Infections fongiques
Gestion des complications
Antifongiques
Infections récurrentes
Immunodépression
Facteurs de risque
5
Facteurs de risque
Immunodépression
Personnes âgées
Facteurs de risque
Diabète
Infections fongiques
Immunosuppresseurs
Facteurs de risque
Voyages
Infections fongiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chrysosporium : Questions médicales les plus fréquentes",
"headline": "Chrysosporium : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chrysosporium : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-07",
"dateModified": "2025-05-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chrysosporium"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Deuteromycota",
"url": "https://questionsmedicales.fr/mesh/D003904",
"about": {
"@type": "MedicalCondition",
"name": "Deuteromycota",
"code": {
"@type": "MedicalCode",
"code": "D003904",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.300.381"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Chrysosporium",
"alternateName": "Chrysosporium",
"code": {
"@type": "MedicalCode",
"code": "D002912",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Anwei Chen",
"url": "https://questionsmedicales.fr/author/Anwei%20Chen",
"affiliation": {
"@type": "Organization",
"name": "College of Resources and Environment, Hunan Agricultural University, Changsha 410128, PR China. Electronic address: A.Chen@hunau.edu.cn."
}
},
{
"@type": "Person",
"name": "Liang Hu",
"url": "https://questionsmedicales.fr/author/Liang%20Hu",
"affiliation": {
"@type": "Organization",
"name": "School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China. Electronic address: huliang2018@csu.edu.cn."
}
},
{
"@type": "Person",
"name": "Sheng-Tao Yang",
"url": "https://questionsmedicales.fr/author/Sheng-Tao%20Yang",
"affiliation": {
"@type": "Organization",
"name": "College of Chemistry and Environment Protection Engineering, Southwest Minzu University, Chengdu, 610041, PR China. Electronic address: yangst@pku.edu.cn."
}
},
{
"@type": "Person",
"name": "Ni He",
"url": "https://questionsmedicales.fr/author/Ni%20He",
"affiliation": {
"@type": "Organization",
"name": "School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China."
}
},
{
"@type": "Person",
"name": "Motoyuki Shimizu",
"url": "https://questionsmedicales.fr/author/Motoyuki%20Shimizu",
"affiliation": {
"@type": "Organization",
"name": "Department of Applied Biological Chemistry, Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan. Electronic address: moshimi@meijo-u.ac.jp."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Norepinephrine activates β",
"datePublished": "2022-05-19",
"url": "https://questionsmedicales.fr/article/35589612",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/glia.24219"
}
},
{
"@type": "ScholarlyArticle",
"name": "Norepinephrine combined with phenylephrine versus norepinephrine in patients with septic shock: a retrospective cohort study.",
"datePublished": "2023-04-07",
"url": "https://questionsmedicales.fr/article/37029365",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12879-023-08142-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Norepinephrine system at the interface of attention and reward.",
"datePublished": "2023-03-16",
"url": "https://questionsmedicales.fr/article/36933778",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pnpbp.2023.110751"
}
},
{
"@type": "ScholarlyArticle",
"name": "Combination of norepinephrine with phenylephrine versus norepinephrine with vasopressin in critically ill patients with septic shock: A retrospective study.",
"datePublished": "2022-07-28",
"url": "https://questionsmedicales.fr/article/35908329",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcrc.2022.154121"
}
},
{
"@type": "ScholarlyArticle",
"name": "Peripheral Administration of Norepinephrine: A Prospective Observational Study.",
"datePublished": "2023-08-21",
"url": "https://questionsmedicales.fr/article/37611862",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.chest.2023.08.019"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Eucaryotes",
"item": "https://questionsmedicales.fr/mesh/D056890"
},
{
"@type": "ListItem",
"position": 3,
"name": "Champignons",
"item": "https://questionsmedicales.fr/mesh/D005658"
},
{
"@type": "ListItem",
"position": 4,
"name": "Deuteromycota",
"item": "https://questionsmedicales.fr/mesh/D003904"
},
{
"@type": "ListItem",
"position": 5,
"name": "Chrysosporium",
"item": "https://questionsmedicales.fr/mesh/D002912"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chrysosporium - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chrysosporium",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chrysosporium",
"description": "Comment diagnostiquer une infection par Chrysosporium ?\nQuels tests sont utilisés pour identifier Chrysosporium ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes indiquent une infection par Chrysosporium ?\nPeut-on utiliser des tests sérologiques pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Norepinephrine#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chrysosporium",
"description": "Quels sont les symptômes courants d'une infection fongique ?\nLes infections cutanées par Chrysosporium sont-elles fréquentes ?\nComment se manifestent les infections pulmonaires ?\nLes infections systémiques sont-elles graves ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Norepinephrine#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chrysosporium",
"description": "Comment prévenir les infections par Chrysosporium ?\nLes personnes immunodéprimées doivent-elles prendre des précautions ?\nLe port de gants est-il recommandé lors de manipulations ?\nLes vaccinations aident-elles à prévenir ces infections ?\nL'hygiène personnelle joue-t-elle un rôle dans la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Norepinephrine#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chrysosporium",
"description": "Quels traitements sont efficaces contre Chrysosporium ?\nLes traitements varient-ils selon la gravité de l'infection ?\nCombien de temps dure le traitement antifongique ?\nDes effets secondaires sont-ils associés aux antifongiques ?\nLes infections par Chrysosporium nécessitent-elles une hospitalisation ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Norepinephrine#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chrysosporium",
"description": "Quelles complications peuvent survenir avec Chrysosporium ?\nLes infections par Chrysosporium peuvent-elles être mortelles ?\nComment les complications sont-elles gérées ?\nLes complications affectent-elles le pronostic ?\nLes infections récurrentes sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Norepinephrine#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chrysosporium",
"description": "Quels sont les principaux facteurs de risque d'infection ?\nLes personnes âgées sont-elles plus à risque ?\nLe diabète augmente-t-il le risque d'infection fongique ?\nLes traitements immunosuppresseurs sont-ils un facteur de risque ?\nLes voyages dans des zones tropicales augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Norepinephrine#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Chrysosporium ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen microscopique et la culture du champignon."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier Chrysosporium ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de culture et des techniques moléculaires comme la PCR peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles nécessaires pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des biopsies peuvent être nécessaires pour confirmer l'infection fongique."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection par Chrysosporium ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des lésions cutanées, des infections pulmonaires ou systémiques."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des tests sérologiques pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques ne sont généralement pas fiables pour Chrysosporium."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une infection fongique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, éruptions cutanées et fatigue."
}
},
{
"@type": "Question",
"name": "Les infections cutanées par Chrysosporium sont-elles fréquentes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des lésions cutanées et des démangeaisons."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les infections pulmonaires ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles se manifestent par une toux persistante, des douleurs thoraciques et des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Les infections systémiques sont-elles graves ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être graves et nécessitent une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et de l'état immunitaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par Chrysosporium ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition à des environnements humides et à des matériaux contaminés aide à prévenir."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées doivent-elles prendre des précautions ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles doivent éviter les environnements à risque et consulter un médecin régulièrement."
}
},
{
"@type": "Question",
"name": "Le port de gants est-il recommandé lors de manipulations ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le port de gants lors de la manipulation de terre ou de matériaux potentiellement contaminés est conseillé."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir ces infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il n'existe pas de vaccin spécifique contre les infections par Chrysosporium."
}
},
{
"@type": "Question",
"name": "L'hygiène personnelle joue-t-elle un rôle dans la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hygiène personnelle peut réduire le risque d'infections fongiques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre Chrysosporium ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antifongiques comme l'itraconazole et le voriconazole sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon la gravité de l'infection ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections légères peuvent être traitées par voie orale, tandis que les cas graves nécessitent une perfusion."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement antifongique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement peut varier de plusieurs semaines à plusieurs mois selon la gravité."
}
},
{
"@type": "Question",
"name": "Des effets secondaires sont-ils associés aux antifongiques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des nausées, des éruptions cutanées et des problèmes hépatiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les infections par Chrysosporium nécessitent-elles une hospitalisation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la gravité de l'infection; les cas graves peuvent nécessiter une hospitalisation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec Chrysosporium ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections systémiques graves et des lésions pulmonaires."
}
},
{
"@type": "Question",
"name": "Les infections par Chrysosporium peuvent-elles être mortelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en particulier chez les personnes immunodéprimées, elles peuvent être fatales."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications nécessitent souvent des traitements antifongiques intensifs et un suivi médical."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles le pronostic ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la présence de complications peut aggraver le pronostic et prolonger la durée de traitement."
}
},
{
"@type": "Question",
"name": "Les infections récurrentes sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections récurrentes peuvent survenir, surtout chez les patients immunodéprimés."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immunodépression, le diabète et l'exposition à des environnements humides."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru en raison d'un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Le diabète augmente-t-il le risque d'infection fongique ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut affaiblir le système immunitaire et augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les traitements immunosuppresseurs sont-ils un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements immunosuppresseurs augmentent le risque d'infections fongiques."
}
},
{
"@type": "Question",
"name": "Les voyages dans des zones tropicales augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages dans des zones tropicales peuvent exposer à des agents pathogènes fongiques."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 02/05/2025
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
Affiliations :
College of Resources and Environment, Hunan Agricultural University, Changsha 410128, PR China. Electronic address: A.Chen@hunau.edu.cn.
4 publications dans cette catégorie
Affiliations :
School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China. Electronic address: huliang2018@csu.edu.cn.
Publications dans "Chrysosporium" :
4 publications dans cette catégorie
Affiliations :
College of Chemistry and Environment Protection Engineering, Southwest Minzu University, Chengdu, 610041, PR China. Electronic address: yangst@pku.edu.cn.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
Department of Applied Biological Chemistry, Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan. Electronic address: moshimi@meijo-u.ac.jp.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
Biocatalysis and Biosensing Laboratory, Department of Food Science and Technology, BOKU-University of Natural Resources and Life Sciences, Muthgasse 18, 1190, Vienna, Austria.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
Biocatalysis and Biosensing Laboratory, Department of Food Science and Technology, BOKU-University of Natural Resources and Life Sciences, Muthgasse 18, 1190, Vienna, Austria.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
Biocatalysis and Biosensing Laboratory, Department of Food Science and Technology, BOKU-University of Natural Resources and Life Sciences, Muthgasse 18, 1190, Vienna, Austria. roland.ludwig@boku.ac.at.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
Faculty of Agriculture, Kyushu University, 6-10-1 Hakozaki, Higashi-ku, Fukuoka, 812-8581, Japan.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Resources and Environment, Hunan Agricultural University, Changsha 410128, PR China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Resources and Environment, Hunan Agricultural University, Changsha 410128, PR China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Resources and Environment, Hunan Agricultural University, Changsha 410128, PR China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Environmental Science and Engineering, Hunan University and Key Laboratory of Environmental Biology and Pollution Control (Hunan University), Ministry of Education, Changsha 410082, PR China. Electronic address: zgming@hnu.edu.cn.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Environmental Science and Engineering, Hunan University and Key Laboratory of Environmental Biology and Pollution Control (Hunan University), Ministry of Education, Changsha 410082, PR China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Resources and Environmental Science, Yunnan Agricultural University, Kunming 650201, China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Resources and Environmental Science, Yunnan Agricultural University, Kunming 650201, China. Electronic address: xuzhi9910@126.com.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Environmental Science and Engineering, Hunan University, Changsha 410082, PR China; Key Laboratory of Environmental Biology and Pollution Control, Hunan University, Ministry of Education, Changsha 410082, PR China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Environmental Science and Engineering, Hunan University, Changsha 410082, PR China; Key Laboratory of Environmental Biology and Pollution Control, Hunan University, Ministry of Education, Changsha 410082, PR China.
Publications dans "Chrysosporium" :
2 publications dans cette catégorie
Affiliations :
School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China.
Publications dans "Chrysosporium" :
2 publications dans cette catégorie
Affiliations :
School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China.
Publications dans "Chrysosporium" :
Norepinephrine exerts powerful influences on the metabolic, neuroprotective and immunoregulatory functions of astrocytes. Until recently, all effects of norepinephrine were believed to be mediated by ...
Phenylephrine (PE) and norepinephrine (NE) may be used to maintain adequate blood pressure and tissue perfusion in patients with septic shock, but the effect of NE combined with PE (NE-PE) on mortalit...
This single-center, retrospective cohort study included adult patients with septic shock. According to the infusion type, patients were divided into the NE-PE or NE group. Multivariate logistic regres...
Among 1, 747 included patients, 1, 055 received NE and 692 received NE-PE. For the primary outcome, the hospital mortality rate was higher in patients who received NE-PE than in those who received NE ...
NE combined with PE was inferior to NE alone in patients with septic shock, and it was associated with a higher hospital mortality rate....
Reward learning is key to survival for individuals. Attention plays an important role in the rapid recognition of reward cues and establishment of reward memories. Reward history reciprocally guides a...
To evaluate the outcomes of patients with septic shock treated with a combination of norepinephrine with phenylephrine compared to norepinephrine with vasopressin....
This was a retrospective cohort study including adults admitted between 2002 and 2017 with septic shock according to the Sepsis 3 criteria. We compared outcomes of patients treated with norepinephrine...
During the study period, 158 patients with septic shock were treated with norepinephrine with phenylephrine and 129 with norepinephrine with vasopressin. Crude in-hospital mortality was not different ...
Phenylephrine used as a second-line vasoactive agent combined with norepinephrine may be a reasonable option compared to vasopressin. However, this finding needs to be validated in a randomized contro...
Historically, norepinephrine has been administered through a central venous catheter (CVC) because of concerns about the risk of ischemic tissue injury if extravasation from a peripheral IV catheter (...
Can a protocol for peripheral norepinephrine administration safely reduce the number of days a CVC is in use and frequency of CVC placement?...
This was a prospective observational cohort study conducted in the medical ICU at a quaternary care academic medical center. A protocol for peripheral norepinephrine administration was developed and i...
The primary outcome was the number of days of CVC use that were avoided per patient, and the secondary safety outcomes included the incidence of extravasation events. Six hundred thirty-five patients ...
This study suggests that implementing a protocol for peripheral administration of norepinephrine safely can avoid 1 CVC day in the average patient, with 51.6% of patients not requiring CVC insertion. ...
Sepsis is a major health problem in the United States (US), constituting a leading contributor to mortality among critically ill patients. Despite advances in treatment the underlying pathophysiology ...
While the pillars of trauma resuscitation are surgical hemostasis and blood product administration, norepinephrine (NE) can be used as an adjunct. The goal of this study was to evaluate the relationsh...
Patients admitted between January 2013 and January 2021 treated with NE were reviewed. Univariate and multivariate logistic regression were used to assess whether maximum NE dose was independently ass...
Three hundred fifty-first trauma patients were included, with 217 (62%) surviving. Patients who died received an average maximum dose of 16.7 mcg/min compared to 9.1 mcg/min in survivors (P = 0.0003)....
Higher maximum doses of NE were associated with increased mortality. Patients initiated on NE more than 24 h into their admission displayed an inflection point at a lower dose than those initiated lat...
Norepinephrine (NE), a neurotransmitter, has multiple functions in the neural system and peripheral organs. Abnormal levels of NE may lead to numerous neuro-degenerative and psychiatric disorders, suc...
During hemorrhagic shock, blood loss causes a fall in blood pressure, decreases cardiac output, and, consequently, O...
While the history of neuroimmunology is long, the explicit study of neuroimmune communication, and particularly the role of catecholamines in neuroimmunity, is still emerging. Recent studies have show...